Conscientious & Rational Prescribing

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/70

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:54 AM on 8/25/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

71 Terms

1
New cards

Pure Food and Drug Act of 1906

prohibited mislabeling and adulteration of drugs

2
New cards

Opium Exclusion Act of 1909

prohibited importation of opium

3
New cards

Amendment (1912) to the Pure Food and Drug Act

Prohibited false or fraudulent advertising claims

4
New cards

Harrison Narcotic Act of 1914

established regulations for use of opium, opiates, and cocaine (marijuana added in 1937)

5
New cards

Food, Drug, and Cosmetic Act of 1938

required that new drugs be safe and pure (but did not require proof of efficacy), enforced by FDA

6
New cards

Durham-Humphrey Act of 1952

Vested in the FDA the power to determine which products could be sold without a prescription.

7
New cards

Kefauver-Harris Amendment of 1962 to Food, Drug, and Cosmetic Act

required proof of efficacy and safety for new drugs and for drugs release since 1938, established guidelines for reporting of info about adverse reactions, clinical testing, and advertising of new drugs

8
New cards

Comprehensive Drug Abuse Prevention and Control Act of 1970

outlined strict controls in manufacture, distribution, and prescribing of habit-forming drugs, established drug schedules and programs to prevent and treat drug addiciton

9
New cards

Orphan Drug Amendment of 1983

Provided incentives for development of drugs that treat diseases with fewer than 200,000 patients in the USA

10
New cards

Drug Price Competition and Patent Restoration Act of 1984

manufacturers pay user fees for certain new drug applications, "breakthrough" products may receive special category approval after expanded phase 1 trials

11
New cards

Bioterrorism Act of 2002

Enhanced controls on dangerous biologic agents and toxins. Seeks to protect safety of food, water, and drug supply

12
New cards

Dietary Supplement Health and Education Act of 1994

established standards with respect to dietary supplements but prohibited full FDA review of supplements and botanicals as drugs

required the establishment of specific ingredient and nutrition information labeling that defines dietary supplements and classifies them as part of food supply but allows unregulated advertising

13
New cards

food and drug administration amendments act of 2007

granted FDA greater authority over drug marketing, labeling, direct-to-consumer advertising, required post-approval studies, established active surveillance systems, made clinical trial operations and results more visible to public

14
New cards

Biologics Price Competition and Innovation Act of 2009

authorized FDA to establish a program of abbreviated pathways for approval of "biosimilar" biologics

15
New cards

FDA Safety and Innovation Act of 2012

Renewed FDA authorization for *accelerated approval of urgently needed drugs*; established new accelerated process, "breakthrough therapy," in addition to "priority review," "accelerated approval" and *"fast-track" procedures*.

16
New cards

what does the FDA require manufacturers to demonstrate?

- free from adulteration (contaminated)

- free from misbranding/mislabeling

- safety & efficacy data for proposed med

17
New cards

what are the phases of clinical testing?

Phase 1 - done in healthy volunteers

Phase 2 - done in 100's of volunteers with illness being studied, looks at dosing, efficacy, adverse effects

Phase 3 - larger group, double blind placebo controlled, looks at dosing, efficacy, adverse effects

Phase 4 - takes years, post marketing surveillance phase, looks at long term effects

<p>Phase 1 - done in healthy volunteers</p><p>Phase 2 - done in 100's of volunteers with illness being studied, looks at dosing, efficacy, adverse effects </p><p>Phase 3 - larger group, double blind placebo controlled, looks at dosing, efficacy, adverse effects </p><p>Phase 4 - takes years, post marketing surveillance phase, looks at long term effects</p>
18
New cards

what happened with thalidomide, inspiring changes to regulations?

did not undergo testing before and was given to pregnant women for N/V

resulted in 40% survival rate

19
New cards

what is the FDA is established to do?

protect public from harmful drugs

20
New cards

what are the 2 drug classes?

OTC and Legend (prescription)

21
New cards

what are over the counter drugs (OTC)?

no prescription required, manufacturer must provide general directions for use

22
New cards

what are legend (prescription) drugs?

must come with adequate directions for a health professional to prescribe

23
New cards

what does a prescription package insert contain info about?

drug PK/PD, approved indications, dosage/administration, side effects, cautions, monitoring

24
New cards

what act governs the regulation of dietary supplements?

Dietary Supplement Health and Education Act (DSHEA)

25
New cards

what are examples of dietary supplements?

-vitamin, mineral, herb or other botanical

- amino acid

- substance consumed to supplement the diet by increasing the total dietary intake

- concentrate, metabolite, constituent, extract

- combination of any of the above

26
New cards

the FDA has the authority to remove dietary supplements from the marketplace if...

- pose a "significant or unreasonable risk to consumers"

- adulterated

- marketed with inaccurate labeling

27
New cards

what is "Off-Label" use?

FDA-approved drug prescribed for condition, age group or in a manner not approved by the FDA

- cannot market off-label indications

- providers can prescribe for other uses

28
New cards

what is an example of off label use?

ceftaroline (Teflaro) - antibiotic for skin and soft tissue infections and pneumonia but can be used fro blood stream infections (off label)

29
New cards

what are some other examples of off label use?

weight loss shots, Xarelto

30
New cards

who enforces regulation of controlled substances?

enforced by DEA and Department of Justice

31
New cards

what are controlled substances?

opiates, sedatives, stimulants, hallucinogens

32
New cards

how are controlled substances categorized?

Schedule I (C-I) with a high potential for abuse to Schedule V (C-V) with a low potential for abuse

33
New cards

C-I Drugs

- high potential for abuse

- no accepted medical use in US

34
New cards

what is an example of a CS-I Drug?

-heroin

-LSD

35
New cards

CS-II Drugs

- high potential for abuse, physical and psychological dependency

- Rx, no strike overs

- NO REFILLS

-VO for emergencies for 72 hrs

36
New cards

what is an example of a CS-II Drug?

-hydromorphone

-oxycodone

-fentanyl

-morphine

-hydrocodone (APAP)

37
New cards

CS-III Drugs

- some potential for abuse, moderate psychological dependency

- Rx

- 5 refills within 6 months

38
New cards

what is an example of a CS-III Drug?

Tylenol with codeine

39
New cards

CS-IV Drugs

- low potential for abuse, limited psychological & physical dependency

- Rx

- 5 refills within 6 months

40
New cards

what is an example of a CS-IV Drug?

-alprazolam (Xanax)

-zolpidem (Ambien)

-tramadol

-carisoprodal

41
New cards

CS-V Drugs

- requires prescription

- Rx

- 5 refills within 6 months

42
New cards

what is an example of a CS-V Drug?

- lomotil

-robitussin with codeine

43
New cards

how should you write out the quanitity, especially on CS-II scripts?

write out the quantity, "sixty" not 60

44
New cards

CS-II rx writing tips

- "ongoing use" written on face

- date script

- write date script written

- no strike outs

45
New cards

how many medication errors are there per year?

180,000

46
New cards

how many ED visits and hospitalizations are due to ADEs annually?

1 million ED, >250,000 hosp.

47
New cards

how much is spent on extra medical costs of ADEs annually?

3.5 billion

48
New cards

what often causes medication errors?

- failed communication

- poor drug distribution (mail)

- complex/poor designed technology

- access to drugs by non-pharm (samples)

- dose miscalculations

- lack of info of patient history

- allow pt to leave before understanding therapy/drug

49
New cards

what are some types of medication errors?

-errors of omission

-poor prescription writing

-inappropriate drug prescribing

50
New cards

what are errors of omission?

assumption such as "resume home meds"

fails to specify strength, long acting formulation, "prn"

51
New cards

what cause poor prescription writing?

ambiguous decimal point, abbreviations

52
New cards

what could cause inappropriate drug prescribing?

failure to recognize contraindications

ex. drug interactions with drugs, foods, diseases

53
New cards

how does the FDA provide oversight of safety issues for safe medication practices?

- oversight associated with similarly named drugs

ex. Kapidex -> Dexilant

54
New cards

what was Kapidex name changed to Dexilant?

proton pump inhibitor that sounded too similar to a chemo drug, so changed the name

55
New cards

what are the two national reporting systems for medication errors?

-voluntary

-mandatory

56
New cards

what is the voluntary national reporting systems for medication errors?

provides confidential feedback to health providers so they can learn from other's mistakes

57
New cards

what is the mandatory national reporting systems for medication errors?

makes medication errors known the the public

58
New cards

what is on the USP's list of recommendations to improve the accuracy of presciption writing?

- brief notation of purpose

- write in metric system except insulin, vitamins

-include age and weight of pt

- leading zero should ALWAYS be used for decimal less than 1 (0.5g)

-terminal zero shoulder NEVER be used after decimal (5g not 5.0g)

-avoid abbreviations

59
New cards

what should be included for prescriber identification?

name, degree, office address, telephone number

60
New cards

what should be included for patient identifiers?

name and address

61
New cards

what should be included for inscription?

name of drug and strength

62
New cards

what should be included for DAW?

DAW with signature in correct box

63
New cards

what should be included for subscription?

instructions to pharmacist regarding dosage form and number of dosage units to dispense

64
New cards

what should be included for signa?

instructions by provider given to the patient

65
New cards

Pregnancy Safety Category A description

-no risk to fetus in 1st trimester

-no evidence of risk in later trimesters

66
New cards

Pregnancy Safety Category A example

-levothyroxine

-magnesium sulfate

67
New cards

Pregnancy Safety Category B description

no risk to fetus in animal studies, but no well-controlled studies in pregnant women

68
New cards

Pregnancy Safety Category B example

-HCTZ

-Amox/clav

69
New cards

Pregnancy Safety Category X description

-fetal abnormalities reported and positive evidence of fetal risk in humans

-risk outweigh benefits

-drugs should NOT be used in pregnant women

70
New cards

Pregnancy Safety Category X example

-warfarin

-simvastatin

71
New cards

how you stay vigilant for adverse drug effects?

- maintain high suspicion for ADE

-educate pt about potential side effects

-be alert for withdrawal symptoms masquerading as relapses